Despite a personal endorsement and use by President Donald Trump, the Food and Drug Administration on Monday revoked its emergency use authorization for hydroxychloroquine as a way to treat the Coronavirus, as the feds say the side effects caused by the drug outweigh any benefits of its use.
In a statement, the FDA said it had "determined that chloroquine and hydroxychloroquine are unlikely to be effective in treating COVID-19."
"Additionally, in light of ongoing serious cardiac adverse events and other potential serious side effects, the known and potential benefits of chloroquine and hydroxychloroquine no longer outweigh the known and potential risks for the authorized use," the statement added.
In a statement, FDA officials said "hydroxychloroquine showed no benefit on mortality or in speeding recovery" for those with the Coronavirus, as the agency cited a 'rigorous assessment' by government scientists.
© 2020 Cox Media Group